Cargando…
Molecular Imaging of Tumor Microenvironment to Assess the Effects of Locoregional Treatment for Hepatocellular Carcinoma
Liver cancer is one of the leading causes of cancer deaths worldwide. Among all primary liver cancers, hepatocellular carcinoma (HCC) is the most common type, representing 75%‐85% of all primary liver cancer cases. Median survival following diagnosis of HCC is approximately 6 to 20 months due to lat...
Autores principales: | Chen, Quan, Chen, Austin Z., Jia, Guorong, Li, Jindian, Zheng, Chuansheng, Chen, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948593/ https://www.ncbi.nlm.nih.gov/pubmed/34738743 http://dx.doi.org/10.1002/hep4.1850 |
Ejemplares similares
-
Image-guided locoregional non-intravascular interventional treatments for hepatocellular carcinoma: Current status
por: Qian, Kun, et al.
Publicado: (2020) -
Modulating the tumor immune microenvironment with locoregional image-guided interventions
por: Jain, Samagra, et al.
Publicado: (2023) -
Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Zane, Kylie E., et al.
Publicado: (2021) -
MRI assessment of hepatocellular carcinoma after locoregional therapy
por: Hussein, Rasha S., et al.
Publicado: (2019) -
Locoregional Therapies and Remodeling of Tumor Microenvironment in Pancreatic Cancer
por: De Grandis, Maria Caterina, et al.
Publicado: (2023)